VERA - CIK 0001831828
Vera Therapeutics, Inc. (VERA) reported net income of -$299.62M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | -$299.62M | -96.9% |
| FY 2024 | -$152.15M | -58.5% |
| FY 2023 | -$95.99M | -7.8% |
| FY 2022 | -$89.06M | -173.1% |
| FY 2021 | -$32.61M | +38.9% |
| FY 2020 | -$53.41M | - |
Vera Therapeutics, Inc. (VERA) reported net income of -$299.62M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2020 and fiscal 2025, Vera Therapeutics, Inc.'s net income declined from -$53.41M to -$299.62M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.